By Kelsey GoodwinAugust 22, 2022
Being able to see and experience the direct patient impact of this research has been incredibly rewarding, and further inspires me to pursue a career within the biomedical field.
~Bonner Kirkland 23
Name: Bonner Kirkland 23Hometown: Nashville, TennesseeMajor: Engineering Integrated with Biology
Q: What factors led you to choose W&L?I was immediately drawn to W&L by the strong sense of community on campus, as the honor system and speaking tradition reinforce a sense of trust and camaraderie among students and faculty. I was also drawn to the small class sizes, which Ive found to be extremely valuable to my learning process. I knew I wanted to pursue a science, technology, engineering and mathematics (STEM) major, and that being able to work in smaller groups of students closely alongside professors would greatly facilitate my ability to learn and develop skills that can be applied later in life. W&Ls strong alumni network was also very appealing to me, and the ability to connect with and seek career advice from alums is another valuable aspect of our community.
Q: Why did you choose your course of study?I knew I wanted to pursue a major within the STEM field when I arrived at college, but was undecided on what specific topics I was interested in. After taking Physics I in my first semester with Professor Irina Mazilu, I immediately fell in love with not only the subject matter, but also the Physics and Engineering Department. Each of the professors in this department genuinely care about their students growth, both in and outside of the classroom. They constantly volunteer their time to ensure students reach mastery of the difficult subject matter. My love for problem solving, math and science partnered with wonderful professors prompted me to pursue an engineering major. Ive thoroughly enjoyed the engineering coursework Ive taken which has exposed me to a variety of engineering topics, from electrical circuits to fluid mechanics.
The ability to integrate the engineering major with another science discipline in my case, biology enabled me to take a variety of biology courses in addition to engineering classes. Ive always wanted to pursue a career within the medical field, specifically biomedical engineering, so this major has allowed me to supplement my engineering skillset with biological knowledge that will help me in the future.
Q: How did you find out about this opportunity? Did anyone at W&L help?I briefly worked in the same lab through a program offered by my high school in 2018. Knowing I wanted to pursue a medical research position this summer, I reached out to my previous lab supervisor to see if he had any open positions for student research and he graciously welcomed me back into his lab. Because this is an unpaid position, this experience was made possible entirely through the generosity of W&L donors and summer funding opportunities, particularly the Johnson Opportunity Grant, Department of Physics and Engineerings supplemental summer funding, and Career and Professional Development funding. I am incredibly grateful for financial support from both the school and generous donors, allowing me to pursue this research position by offsetting the costs of living and working in Washington, D.C.
Q: What kind of work are you doing?This summer I conducted research in the Childrens National Hospitals Department of Genetic Medicine, where we are working on developing a quicker and more cost-effective method for determining abnormalities in amino acid concentrations in newborns. Traditional methods for evaluating amino acid concentrations in patients have been costly, timely and often require a large volume of sample. The method we are developing, on the other hand, requires a small sample and allows for the quick and proactive diagnosis of various genetic conditions in newborns marked by unique amino acid levels.
We are also working on a project to evaluate how glutathione, a combination of three amino acids, works to relieve cellular damage caused by oxidative stress in cells. Glutathione acts as an antioxidant defense against oxidative stress, preventing damage to the cells. This project will reveal how glutathione may work as an anti-aging mechanism that strengthens the immune system, detoxifies the body and eliminates carcinogens. All summer, I have been maintaining, growing, and plating HepG2 cells, then treating them with various concentrations of hydrogen peroxide to cause oxidative damage. Then I either pre- or post- treat these cells with gamma-glutamylcysteine a precursor amino acid to glutathione and analyze how this facilitates cell recovery. This work requires close attention to detail and sterile technique as to not contaminate the cells.
Q: What do you like most about it, and what has been most challenging so far?Having the opportunity to work with patient samples has definitely been a highlight of this internship. Recently, through use of this new method, researchers in the lab noticed that patients suffering from sickle cell anemia had low levels of citrulline, a critical amino acid which regulates vasodilation. These low levels of citrulline cause vasoconstriction and thus, we hypothesize chronic pain. After administering a dose of citrulline to several patients suffering from severe pain, they reported significantly reduced pain levels. The prospect of being able to use a naturally occurring amino acid rather than morphine to mitigate pain in these young patients is extremely valuable. Being able to see and experience the direct patient impact of this research has been incredibly rewarding, and further inspires me to pursue a career within the biomedical field.
I have also enjoyed being able to work on a project of my own, analyze the data and present my findings. The glutathione project Im currently working on has been challenging, confusing and frustrating at times, particularly when the data comes out differently than expected. However, it has taught me that research is rarely clean cut and perfect on the first try. It takes frequent repetition and minor tweaking of procedures to yield the desired results. Towards the end of the summer, I was able to present my results in our departments lab meeting, which was an exciting and meaningful experience. Sharing the culmination of my summers work with people working in different labs allowed me to gain more experience giving scientific presentations to people of different backgrounds.One of the most difficult elements of this research experience has been having to quickly familiarize myself with complex biochemistry and genetic topics. The majority of my coursework focuses on standard engineering classes and some biology classes, whereas this research is heavily based in chemistry. Becoming familiar with the different chemical and biological pathways involved in this project has definitely been a steep learning curve. However, I make up for my lack of prior chemistry coursework by reading relevant literature to the project and papers this lab has published in the past, as well as actively communicating any questions I have with my lab supervisor.
Q: Tell us about previous summer experiences youve had at W&L.Last summer, I worked as a compliance engineer intern for TVP Health, formerly known as The Ventilator Project. This nonprofit organization was founded in March 2020 in response to the COVID-19 pandemic with the mission of ensuring all people have access to quality medical care amid a global ventilator shortage. TVP Health developed a lower-cost ventilator, called AIRA, to combat this global issue. As a compliance engineer, I worked to ensure AIRA met various ISO medical device standards. This initial exposure to the medical device industry piqued my interest in the field and prompted me to consider a career path in biomedical engineering, as the intersection between engineering and direct patient impact is very important to me.
Q: How do you think your current summer experience and others youve had in the past, if applicable will impact your future career path?I have been interested in the sciences and problem solving for as long as I can remember, but my passion for integrating medicine with engineering began through my aforementioned internship with TVP Health. Last summers experience dealt with the more technical, regulatory side of the medical device industry, so I have really enjoyed this summers research, as it pertains more to the hands on, biological side of medical research. Gaining exposure to these two aspects of the industry will be incredibly formative in my future career endeavors.
My research experience at Childrens National Hospital immersed me in the field of biomedical research. I was given the opportunity to learn and practice sterile lab technique, the scientific method and the problem-solving methods used in the scientific world. This internship has also taught me the importance of communication with coworkers and superiors, as well as how to proactively avoid problems in a lab setting and think critically to respond in unfamiliar situations. After graduation, I hope to pursue a masters degree in biomedical engineering, and everything I have learned from my summer experiences will be incredibly valuable throughout graduate school and beyond.
I hope to focus my skillset on the medical device industry, particularly within the realm of womens health and medicine. Women are often underrepresented in clinical trials due to the complex, variable female hormone system. This can lead to women being misdiagnosed and prescribed the wrong medication, resulting in further health complications because women may react differently to a medication or medical device tested in a predominantly-male clinical trial. This injustice inspires me to develop female-centered medical devices and treatment methods, and I believe my current research opportunity is an early steppingstone to the field of medical research for me.
Q: Outside of your internship, what have you enjoyed the most about living and working in Washington D.C.?One of my favorite parts about Washington D.C. is the walkability of the city and the access to public spaces. In my free time, Ive loved going to Smithsonian museums, walking on the National Mall, going to the farmers market, and running in Rock Creek Park. I especially loved visiting the National Arboretum and seeing their current Ikebana exhibit. Ive learned that having access to quality outdoor spaces is something that is a very important factor to me when choosing a city to live in after graduation.
Q: What do you miss most about W&L when youre away for the summer?While being in a bigger city is exciting and lively, I definitely do miss W&L when Im away. Living on a small, welcoming and safe campus like ours is something I often take for granted during the academic year. The sense of community on campus is one of my favorite parts about being a W&L student. Having time away from school makes me grateful for aspects of our community like the honor system and speaking tradition, which unfortunately are not as prevalent in other places. I also miss the day-to-day interactions with people on campus, whether its grabbing lunch at Caf 77 with a friend or catching up with a professor between classes.
If you know any W&L students who would be great profile subjects, tell us about them! Nominate them for a web profile.
Follow this link:
The Columns Stepping Stones in STEM Washington and Lee University - The Columns
- Clemson professor Trudy Mackay elected to the National Academy of Medicine - Clemson News - October 22nd, 2024
- Research sheds new light on the behavior of KRAS gene in pancreatic and colorectal cancer - News-Medical.Net - October 22nd, 2024
- Pushing the boundaries of rare disease diagnostics with the help of the first Undiagnosed Hackathon - Nature.com - October 22nd, 2024
- Tailored Genetic Medicine: AAV Gene Therapy and mRNA Vaccines Redefine Healthcare's Future - Intelligent Living - October 22nd, 2024
- The Genetic Link to Parkinson's Disease - Hopkins Medicine - August 27th, 2022
- Epic Bio makes gene therapies by editing the epigenome - Labiotech.eu - August 27th, 2022
- Ovid turns to gene therapy startup to restock drug pipeline - BioPharma Dive - August 27th, 2022
- Whole-exome analysis of 177 pediatric patients with undiagnosed diseases | Scientific Reports - Nature.com - August 27th, 2022
- First Gene Therapy for Adults with Severe Hemophilia A, BioMarin's ROCTAVIAN (valoctocogene roxaparvovec), Approved by European Commission (EC) -... - August 27th, 2022
- Arbor Biotechnologies Enters into Agreement with Acuitas Therapeutics for Lipid Nanoparticle Delivery System for Use in Rare Liver Diseases - BioSpace - August 27th, 2022
- ElevateBio Partners with the California Institute for Regenerative Medicine to Accelerate the Development of Regenerative Medicines - Business Wire - August 27th, 2022
- ElevateBio and the University of Pittsburgh Announce Creation of Pitt BioForge BioManufacturing Center at Hazelwood Green to Accelerate Cell and Gene... - August 27th, 2022
- Genetic variants cause different reactions to psychedelic therapy - The Well : The Well - The Well - August 27th, 2022
- Personalized Medicine for Prostate Cancer: What It Is and How It Works - Healthline - August 27th, 2022
- Four radical new fertility treatments just a few years away from clinics - The Guardian - August 27th, 2022
- Why are Rats Used in Medical Research? - MedicalResearch.com - August 27th, 2022
- Study points to new approach to clearing toxic waste from brain Washington University School of Medicine in St. Louis - Washington University School... - August 27th, 2022
- ALS Gene Therapy SynCav1 Found to Extend Survival in Mouse Model |... - ALS News Today - August 27th, 2022
- A New Kind of Chemo | The UCSB Current - The UCSB Current - August 27th, 2022
- Unraveling the mystery of who gets lung cancer and why - Genetic Literacy Project - June 16th, 2022
- How diet and the microbiome affect colorectal cancer - EurekAlert - June 16th, 2022
- Akouos Presents Nonclinical Data Supporting the Planned Clinical Development of AK-OTOF and Strategies for Regulated Gene Expression in the Inner Ear... - May 20th, 2022
- Money on the Move: SwanBio, Remix, Locus, Mirvie and More - BioSpace - May 20th, 2022
- DiNAQOR Opens DiNAMIQS Subsidiary to Partner with Gene Therapy Companies Bringing New Treatments to Patients - PR Newswire - May 20th, 2022
- Brain tumor growth may be halted with breast cancer drug - Medical News Today - May 20th, 2022
- LogicBio Therapeutics to Present at HC Wainwright Global Investment Conference - PR Newswire - May 20th, 2022
- Genascence Announces Data From Phase 1 Clinical Trial on GNSC-001, Company's Lead Program in Osteoarthritis, Presented at American Society of Gene... - May 20th, 2022
- Encoded Therapeutics Presents Nonclinical Data Showing Genomic Medicine Platform Yields Selective Expression to Optimize Gene Therapy Performance at... - May 20th, 2022
- California, Other States to Cover Rapid WGS of Newborns Under Medicaid, but Questions of Access Loom - GenomeWeb - May 20th, 2022
- Researchers Identify Role of 'Sonic the Hedgehog' Gene in Bone Repair - BioSpace - May 20th, 2022
- Targeting the Uneven Burden of Kidney Disease on Black Americans - The New York Times - May 20th, 2022
- ASC Therapeutics, U Mass Medical School, and the Clinic for Special Children Announce Podium Presentation of Safety and Efficacy in Murine and Bovine... - May 20th, 2022
- UC Davis Looks to Expand Genetic Breast Cancer Risk Education, Outreach for Hispanic Women - Precision Oncology News - May 20th, 2022
- Fly Researchers Find Another Layer to the Code of Life - Duke Today - May 20th, 2022
- CANbridge-UMass Chan Medical School Gene Therapy Research Presented at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting - Business... - May 20th, 2022
- Omicron BA.4 and BA.5: What to know about the new variants - Medical News Today - May 20th, 2022
- Krystal Biotech to Present Additional Data on B-VEC from the GEM-3 Phase 3 Study at the Society for Investigative Dermatology Annual Meeting -... - May 20th, 2022
- FDA approves Lilly's Mounjaro (tirzepatide) injection, the first and only GIP and GLP-1 receptor agonist for the treatment of adults with type 2... - May 20th, 2022
- Elucidating the developmental origin of life-sustaining adrenal glands | Penn Today - Penn Today - May 20th, 2022
- 5 questions facing gene therapy in 2022 - BioPharma Dive - January 17th, 2022
- In a First, Man Receives a Heart From a Genetically Altered Pig - The New York Times - January 17th, 2022
- Antibodies, Easy Single-Cell, Genomics for All: Notes from the JP Morgan Healthcare Conference - Bio-IT World - January 17th, 2022
- Using genetics to conserve wildlife - Pursuit - January 17th, 2022
- Genetics of sudden unexplained death in children - National Institutes of Health - January 17th, 2022
- Amicus Therapeutics Reports Preliminary 2021 Revenue and Provides 2022 Strategic Outlook and Revenue Guidance - Yahoo Finance - January 17th, 2022
- Maze Therapeutics Announces $190 Million Financing to Support the Advancement of Nine Precision Medicine Programs and Compass Platform for Genetically... - January 17th, 2022
- How The mRNA Vaccines Were Made: Halting Progress and Happy Accidents - The New York Times - January 17th, 2022
- Press Registration Is Now Open for the 2022 ACMG Annual Clinical Genetics Meeting - PRNewswire - January 17th, 2022
- A Novel Mutation in the TRPM4 Gene | RRCC - Dove Medical Press - January 17th, 2022
- Biomarkers and Candidate Therapeutic Drugs in Heart Failure | IJGM - Dove Medical Press - January 17th, 2022
- Genetic counseling program helps patients take control of their health - Medical University of South Carolina - June 24th, 2021
- One-year-old baby in UAE receives imported genetic medicine to treat rare disease - Gulf News - June 24th, 2021
- Black and non-Hispanic White Women Found to Have No Differences in Genetic Risk for Breast Cancer - Cancer Network - June 24th, 2021
- What's in your genes | The Crusader Newspaper Group - The Chicago Cusader - June 24th, 2021
- Immusoft Announces Formation of Scientific Advisory Board - Business Wire - June 24th, 2021
- Arrowhead Presents Positive Interim Clinical Data on ARO-HSD Treatment in Patients with Suspected NASH at EASL International Liver Congress - Business... - June 24th, 2021
- Pacific Biosciences and Rady Children's Institute for Genomic Medicine Announce its First Research Collaboration for Whole - GlobeNewswire - June 24th, 2021
- Despite the challenges of COVID-19, Yale-PCCSM section members continued their work on scientific papers - Yale School of Medicine - June 24th, 2021
- Veritas Intercontinental: Genetics makes it possible to identify cardiovascular genetic risk and prevent cardiac accidents such as those that have... - June 24th, 2021
- New Research Uncovers How Cancers with Common Gene Mutation Develop Resistance to Targeted Drugs - Newswise - June 24th, 2021
- Celebrate the Third Annual Medical Genetics Awareness Week April 13-16, 2021 - PRNewswire - February 14th, 2021
- How will WNY fare in the race between vaccines and coronavirus variants? - Buffalo News - February 14th, 2021
- Myriad Genetics to Participate in Multiple Upcoming Health and Technology Conferences - GlobeNewswire - February 14th, 2021
- ASCO GU 2021: The Landscape of Genetic Alterations Using ctDNA-based Comprehensive Genomic Profiling in Pat... - UroToday - February 14th, 2021
- The Human Genome and the Making of a Skeptical Biologist - Scientific American - February 14th, 2021
- Breast Cancer Gene Mutations Found in 30% of All Women - Medscape - February 1st, 2021
- Mysterious untreatable fevers once devastated whole families. This doctor discovered what caused them - CNN - February 1st, 2021
- CCMB team identifies variants of genes that metabolise drugs - BusinessLine - February 1st, 2021
- NeuBase Therapeutics Announces Acquisition of Gene Modulating Technology from Vera Therapeutics - GlobeNewswire - February 1st, 2021
- Copy number variations linked to autism have diverse but overlapping effects - Spectrum - February 1st, 2021
- Genomes, Maps, And How They Affect You - IFLScience - February 1st, 2021
- SMART Study Finds 22q11.2 Microdeletion Prevalence Much Higher than Expected - PRNewswire - February 1st, 2021
- Are Phages Overlooked Mediators of Health and Disease? - The Scientist - February 1st, 2021
- When Your Chance for a Covid Shot Comes, Dont Worry About the Numbers - Kaiser Health News - February 1st, 2021
- Global CRISPR Gene Editing Market: Focus on Products, Applications, End Users, Country Data (16 Countries), and Competitive Landscape - Analysis and... - February 1st, 2021
- The First Targeted Therapy For Lung Cancer Patients With The KRAS Gene MutationExtraordinary Results With Sotorasib - SurvivorNet - February 1st, 2021
- Genetic Testing: MedlinePlus - January 29th, 2021
- 21 Common Genetic Disorders: Types, Symptoms, Causes ... - January 29th, 2021
- Genetic Counseling Online Course - School of Medicine ... - January 29th, 2021
- 4 New Life Sciences Licensing Deals and Investments to Watch - BioSpace - January 29th, 2021